NABI BIOPHARMACEUTICALS 4
4 · NABI BIOPHARMACEUTICALS · Filed Apr 6, 2004
Insider Transaction Report
Form 4
GURY DAVID J
Director
Transactions
- Exercise/Conversion
Common Stock
2004-04-05$7.06/sh+6,250$44,144→ 503,809.581 total - Exercise/Conversion
Stock Option (right to buy)
2004-04-05−6,250→ 188,817 totalExercise: $7.06Exp: 2010-02-07→ Common Stock (6,250 underlying) - Tax Payment
Common Stock
2004-04-05$16.09/sh−3,496$56,251→ 500,313.581 total
Holdings
- 102,600(indirect: By immediate family)
Common Stock
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F2]The option became exercisable in four equal annual installments ending on February 7, 2004.